Browsing by Author Naud, P

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:  
Showing results 1 to 20 of 27  next >
PreviewIssue DateTitleAuthor(s)AdvisorType
2010p300 Expression is Related to High-risk Human Papillomavirus Infections and Severity of Cervical Intraepithelial Neoplasia But Not to Viral or Disease Outcomes in a Longitudinal SettingSyrjanen, S; Naud, P; Sarian, L; Derchain, S; Roteli-Martins, C; Longatto, A; Tatti, S; Branca, M; Erzen, M; Serpa-Hammes, L; Matos, J; Arlindo, F; Sakamoto-Maeda, M; Costa, S; Syrjanen, K-Artigo de periódico
2012Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trialLehtinen, M; Paavonen, J; Wheeler, CM; Jaisamrarn, U; Garland, SM; Castellsague, X; Skinner, SR; Apter, D; Naud, P; Salmeron, J; Chow, SN; Kitchener, H; Teixeira, JC; Hedrick, J; Limson, G; Szarewski, A; Romanowski, B; Aoki, FY; Schwarz, TF; Poppe, WAJ; De Carvalho, NS; Germar, MJV; Peters, K; Mindel, A; De Sutter, P; Bosch, FX; David, MP; Descamps, D; Struyf, F; Dubin, G-Artigo de periódico
2009Increased Risk of Oncogenic Human Papillomavirus Infections and Incident High-Grade Cervical Intraepithelial Neoplasia Among Smokers Experience From the Latin American Screening StudySarian, LO; Hammes, LS; Longatto, A; Guarisi, R; Derchain, SFM; Roteli-Martins, C; Naud, P; Erzen, M; Branca, M; Tatti, S; de Matos, JC; Gontijo, R; Maeda, MYS; Lima, T; Costa, S; Syrjanen, S; Syrjanen, K-Artigo de periódico
2012Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trialWheeler, CM; Castellsague, X; Garland, SM; Szarewski, A; Paavonen, J; Naud, P; Salmeron, J; Chow, SN; Apter, D; Kitchener, H; Teixeira, JC; Skinner, SR; Jaisamrarn, U; Limson, G; Romanowski, B; Aoki, FY; Schwarz, TF; Poppe, WAJ; Bosch, FX; Harper, DM; Huh, W; Hardt, K; Zahaf, TK; Descamps, D; Struyf, F; Dubin, G; Lehtinen, M-Artigo de periódico
2009Persistent High-Risk Human Papillomavirus Infections and Other End-Point Markers of Progressive Cervical Disease Among Women Prospectively Followed up in the New Independent States of the Former Soviet Union and the Latin American Screening Study CohortsSyrjanen, K; Shabalova, I; Naud, P; Kozachenko, V; Derchain, S; Zakharchenko, S; Roteli-Martins, C; Nerovjna, R; Longatto, A; Kljukina, L; Tatti, S; Branovskaja, M; Hammes, LS; Branca, M; Grunjberga, V; Erzen, M; Sarian, LO; Juschenko, A; Costa, S; Podistov, J; Syrjanen, S-Artigo de periódico
2005Conventional pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: Experience of the Latin American screening studyLongatto-Filho, A; Maeda, MYS; Erzen, M; Branca, M; Roteli-Martins, C; Naud, P; Derchain, SFM; Hammes, L; Matos, J; Gontijo, R; Sarian, LO; Lima, TP; Tatti, S; Syrjanen, S; Syrjanen, K-Artigo de periódico
2008Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohortSyrjanen, K; Naud, P; Derchain, S; Roteli-Martins, C; Longatto, A; Tatti, S; Branca, M; Erzen, M; Hammes, LS; Matos, J; Gontijo, R; Sarian, L; Braganga, J; Arlindo, FC; Maeda, MYS; Lorincz, A; Dores, GB; Costa, S; Syrjanen, S-Artigo de periódico
2005Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin AmericaSarian, LO; Derchain, SF; Naud, P; Roteli-Martins, C; Longatto, A; Tatti, S; Branca, M; Erzen, M; Serpa-Hammes, L; Matos, J; Gontijo, R; Braganca, JF; Lima, TP; Maeda, MYS; Lorincz, A; Dores, GB; Costa, S; Syrjanen, S; Syrjanen, K-Artigo de periódico
2011Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3Syrjanen, K; Shabalova, I; Naud, P; Derchain, S; Sarian, L; Kozachenko, V; Zakharchenko, S; Roteli-Martins, C; Nerovjna, R; Longatto-Filho, A; Kljukina, L; Tatti, S; Branovskaja, M; Branca, M; Grunjberga, V; Erzen, M; Juschenko, A; Hammes, LS; Costa, S; Podistov, J; Syrjanen, S-Artigo de periódico
2009Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenPaovonen, J; Naud, P; Salmeron, J; Wheeler, CM; Chow, SN; Apter, D; Kitchener, H; Castellsague, X; Teixeira, JC; Skinner, SR; Hedrick, J; Jaisamrarn, U; Limson, G; Garland, S; Szarewski, A; Romanowski, B; Aoki, FY; Schwarz, TF; Poppe, WAJ; Bosch, FX; Jenkins, D; Hardt, K; Zahaf, T; Descamps, D; Struyf, F; Lehtinen, M; Dubin, G-Artigo de periódico
2004Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialHarper, DM; Franco, EL; Wheeler, C; Ferris, DG; Jenkins, D; Schuind, A; Zahaf, T; Innis, B; Naud, P; De Carvalho, NS; Roteli-Martins, CM; Teixeira, J; Blatter, MM; Korn, AP; Quint, W; Dubin, G-Artigo de periódico
2012Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18Szarewski, A; Poppe, WAJ; Skinner, SR; Wheeler, CM; Paavonen, J; Naud, P; Salmeron, J; Chow, SN; Apter, D; Kitchener, H; Castellsague, X; Teixeira, JC; Hedrick, J; Jaisamrarn, U; Limson, G; Garland, S; Romanowski, B; Aoki, FY; Schwarz, TF; Bosch, FX; Harper, DM; Hardt, K; Zahaf, T; Descamps, D; Struyf, F; Lehtinen, M; Dubin, G-Artigo de periódico
2013Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA StudyJaisamrarn, U; Castellsague, X; Garland, SM; Naud, P; Palmroth, J; Del Rosario-Raymundo, MR; Wheeler, CM; Salmeron, J; Chow, SN; Apter, D; Teixeira, JC; Skinner, SR; Hedrick, J; Szarewski, A; Romanowski, B; Aoki, FY; Schwarz, TF; Poppe, WAJ; Bosch, FX; de Carvalho, NS; Germar, MJ; Peters, K; Paavonen, J; Bozonnat, MC; Descamps, D; Struyf, F; Dubin, GO; Rosillon, D; Baril, L-Artigo de periódico
2009Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohortSyrjanen, S; Naud, P; Sarian, L; Derchain, S; Roteli-Martins, C; Longatto, A; Tatti, S; Branca, M; Erzen, M; Hammes, LS; Costa, S; Syrjanen, K-Artigo de periódico
2006Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening studyLongatto, A; Erzen, M; Branca, M; Roteli-Martins, C; Naud, P; Derchain, SFM; Hammes, L; Sarian, LO; Braganca, JF; Matos, J; Gontijo, R; Lima, T; Maeda, MYS; Tatti, S; Syrjanen, S; Dores, G; Lorincz, A; Syrjanen, K-Artigo de periódico
2009Smoking worsens the prognosis of mild abnormalities in cervical cytologyGuarisi, R; Sarian, LO; Hammes, LS; Longatto, A; Derchain, SFM; Roteli-Martins, C; Naud, P; Erzen, M; Branca, M; Tatti, S; Costa, S; Syrjanen, S; Braganca, JF; Syrjanen, K-Artigo de periódico
2011Prevalence of Human Papillomavirus Infection and Associated Risk Factors in Young Women in Brazil, Canada, and the United States: A Multicenter Cross-sectional StudyRoteli-Martins, CM; de Carvalho, NS; Naud, P; Teixeira, J; Borba, P; Derchain, S; Tyring, S; Gall, S; Diaz, A; Blatter, M; Shier, RM; Romanowski, B; Quint, WGV; Issam, J; Galindo, C; Schuind, A; Dubin, G-Artigo de periódico
2012Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trialBahmanyar, ER; Paavonen, J; Naud, P; Salmeron, J; Chow, SN; Apter, D; Kitchener, H; Castellsague, X; Teixeira, JC; Skinner, SR; Jaisamrarn, U; Limson, GA; Garland, SM; Szarewski, A; Romanowski, B; Aoki, F; Schwarz, TF; Poppe, WAJ; De Carvalho, NS; Harper, DM; Bosch, FX; Raillard, A; Descamps, D; Struyf, F; Lehtinen, M; Dubin, G-Artigo de periódico
2008Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS studyDerchain, SF; Sarian, LO; Naud, P; Roteli-Martins, C; Longatto-Filho, A; Tatti, S; Branca, M; Erzen, M; Serpa-Hammes, L; Matos, J; Gontijo, RC; Braganca, JF; Lima, TP; Maeda, MYS; Lorincz, A; Dores, GB; Costa, S; Syrjanen, S; Syrjanen, K-Artigo de periódico
2010Sustained efficacy and immunogenicity of the HPV-16/18 ASO4-adjuvanted vaccine up to 7.3 years in young adult womenDe Carvalho, N; Teixeira, J; Roteli-Martins, CM; Naud, P; De Borba, P; Zahaf, T; Sanchez, N; Schuind, A-Artigo de periódico